Four new antibacterial xanthones from the marine-derived actinomycetes Streptomyces caelestis

Marine Drugs

Volumn 10, Issue 11, 2012, Pages 2571-2583

  Liu, Ling Li ^a   Xu, Ying ^a   Han, Zhuang ^a   Li, Yong Xin ^a   Lu, Liang ^a   Lai, Pok Yui ^a   Zhong, Jia Liang ^b   Guo, Xian Rong ^c   Zhang, Xi Xiang ^c   Qian, Pei Yuan ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY   (China)

^c KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

Author keywords

Antibacterial; Citreamicin; MRSA; Streptomyces caelestis

Indexed keywords

CISPLATIN; CITREAGLYCON A; CITREAMICIN THETA A; CITREAMICIN THETA B; DEHYDROCITREAGLYCON A; PENICILLIN G; STREPTOMYCIN; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ACTINOBACTERIA; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; FERMENTATION; HELA CELL; MARINE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS HAEMOLYTICUS; STREPTOMYCES CAELESTIS;

EID: 84870040743     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md10112571     Document Type: Article

References (30)

1. Gerwick, W.; Moore, B. Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. Chem. Biol. 2012, 19, 85-98.
2. Bhakuni, D.S.; Rawat, D.S. Bioactive Marine Natural Products; Springer: New Delhi, India, 2005; pp. 13-17.
3. Seybold, U.; Kourbatova, E.V.; Johnson, J.G.; Halvosa, S.J.; Wang, Y.F.; King, M.D.; Ray, S.M.; Blumberg, H.M. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care associated blood stream infections. Clin. Infect. Dis. 2006, 42, 647-656. (Pubitemid 43271378)
4. Cosgrove, S.E.; Sakoulas, G.; Perencevich, E.N.; Schwaber, M.J.; Karchmer, A.W.; Carmeli, Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin. Infect. Dis. 2003, 36, 53-59. (Pubitemid 36099097)
5. Engemann, J.J.; Carmeli, Y.; Cosgrove, S.E.; Fowler, V.G.; Bronstein, M.Z.; Trivette, S.L.; Briggs, J.P.; Sexton, D.J.; Kaye, K.S. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis. 2003, 36, 592-598. (Pubitemid 36259564)
6. Cosgrove, S.E.; Qi, Y.; Kaye, K.S.; Harbarth, S.; Karchmer, A.W.; Carmeli, Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infect. Control Hosp. Epidemiol. 2005, 2, 166-174. (Pubitemid 40445022)
7. Klevens, R.M.; Morrison, M.A.; Nadle, J.; Petit, S.; Gershman, K.; Ray, S.; Harrison, L.H.; Lynfield, R.; Dumyati, G.; Townes, M.; et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298, 1763-1771.
8. Deresinski, S. Methicillin-Resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey. Clin. Infect. Dis. 2005, 40, 562-573. (Pubitemid 40270226)
9. Leeb, M. Antibiotics: A shot in the arm. Nature 2004, 431, 892-893.
10. Maiese, W.M.; Lechevalier, M.P.; Lechevalier, H.A.; Korshalla, J.; Goodman, J.; Wildey, M.J.; Kuck, N.; Greenstein, M. LL-E19085 alpha, a novel antibiotic from Micromonospora citrea: Taxonomy, fermentation and biological activity. J. Antibiot. 1989, 42, 846-851. (Pubitemid 19165563)
11. Carter, G.T.; Nietsche, J.A.; Williams, D.R.; Borders, D.B. Citreamicins, novel antibiotics from Micromonospora citrea: Isolation, characterization, and structure determination. J. Antibiot. 1990, 43, 504-512. (Pubitemid 20165227)
12. Reich, M.F.; Lee, V.J.; Ashcroft, J.; Morton, G.O. An unusual cyclization product from the reaction of citreamicin ç with sulfene. J. Org. Chem. 1993, 58, 5288-5290. (Pubitemid 23339848)
13. Hopp, D.C.; Milanowski, D.J.; Rhea, J.; Jacobsen, D.; Rabenstein, J.; Smith, C.; Romari, K.; Clarke, M.; Francis, L.; Irigoyen, M.; et al. Citreamicins with potent gram-positive activity. J. Nat. Prod. 2008, 71, 2032-2035.
14. Peoples, A.J.; Zhang, Q.; Millett, W.P.; Rothfeder, M.T.; Pescatore, B.C.; Madden, A.A.; Ling, L.L.; Moore, C.M. Neocitreamicins I and II, novel antibiotics with activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J. Antibiot. 2009, 61, 457-463.
15. Han, Z.; Xu, Y.; McConnell, O.; Liu, L.; Li, Y.; Qi, S.; Huang, X.; Qian, P. Two antimycin A analogues from marine-derived actinomycete Streptomyces lusitanus. Mar. Drugs 2012, 10, 668-676.
16. Li, S.; Tian, X.; Niu, S.; Zhang, W.; Chen, Y.; Zhang, H.; Yang, X.; Zhang, W.; Li, W.; Zhang, S.; Ju, J.; Zhang, C. Pseudonocardians A-C, new diazaanthraquinone derivatives from a deep-sea Actinomycete Pseudonocardia sp. SCSIO 01299. Mar. Drugs 2011, 9, 1428-1439.
17. Huang, H.; Yang, T.; Ren, X.; Liu, J.; Song, Y.; Sun, A.; Ma, J.; Wang, B.; Zhang, Y.; Huang, C.; Zhang, C.; Ju, J. Cytotoxic angucycline class glycosides from the deep sea actinomycete Streptomyces lusitanus SCSIO LR32. J. Nat. Prod. 2012, 75, 202-208.
18. Schleissner, C.; Perez, M.; Losada, A.; Rodriguez, P.; Crespo, C.; Zuniga, P.; Fernandez, R.; Reyes, F.; De la Calle, F. Antitumor actinopyranones produced by Streptomyces albus POR-04-15-053 isolated from a marine sediment. J. Nat. Prod. 2011, 74, 1590-1596.
19. Kondratyuk, T.P.; Park, E.J.; Yu, R.; Van Breemen, R.B.; Asolkar, R.N.; Murphy, B.T.; Fenical, W.; Pezzuto, J.M. Novel marine phenazines as potential cancer chemopreventive and anti-inflammatory agents. Mar. Drugs 2012, 10, 451-464.
20. w = 0.5021, and S = 1.848. The final model was not very accurate because of the small size of the crystal. The coordinates of the five-member ring and its side chain could not be determined very precisely.
21. Schneider, H.J.; Hacket, F.; Rüdiger, V.; Ikeda, H. NMR studies of cyclodextrins and cyclodextrin complexes. Chem. Rev. 1998, 98, 1755-1786.
22. Caccamese, S.; Manna, L.; Scivoli, G. Chiral HPLC separation and CD spectra of the C-2 diastereomers of naringin in grapefruit during maturation. Chirality 2003, 15, 661-667. (Pubitemid 37158930)
23. Person, R.V.; Monde, K.; Humpf, H.; Berova, N.; Nakanishi, K. A new approach in exciton-coupled circular dichroism (ECCD) - insertion of an auxiliary stereogenic center. Chirality 1995, 7, 128-135.
24. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63. (Pubitemid 14203433)
25. Bozdogan, B.; Appelbaum, P.C. Oxazolidinones: Activity, mode of action, and mechanism of resistance. Int. J. Antimicrob. Agents 2004, 23, 113-119. (Pubitemid 38175391)
26. Patel, U.; Yan, Y.P.; Hobbs, F.W., Jr.; Kaczmarczyk, J.; Slee, A.M.; Pompliano, D.L.; Kurilla, M.G.; Bobkova, E.V. Oxazolidinones mechanism of action: Inhibition of the first peptide bond formation. J. Biol. Chem. 2001, 276, 37199-37205.
27. Sambrook, J.; Fritsch, E.F.; Maniatis, T. Molecular Cloning; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 1989; pp. 914-923.
28. Altschul, S.F.; Madden, T.L.; Schäffer, A.A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D.J. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 1997, 25, 3389-3402. (Pubitemid 27359211)
29. Schmitz, F.J.; Fluit, A.C.; Lückefahr, M.; Engler, B.; Hofmann, B.; Verhoef, J.; Heinz, H.P.; Hadding, U.; Jones, M.E. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 1998, 42, 807-810. (Pubitemid 29008084)
30. Li, Y.; Xu, Y.; Liu, L.; Han, Z.; Lai, P.Y.; Guo, X.; Zhang, X.; Lin, W.; Qian, P.Y. Five new amicoumacins isolated from a marine-derived bacterium Bacillus subtilis. Mar. Drugs 2012, 10, 319-328.